Procedures marked with * may be covered by insurance.

• Bariatric/Banding Weightloss*
• Body Lift
• Botox for Hyperhydrosis
• Botox®
• Brachioplasty
• Breast Augmentation
• Breast Implants
• Breast Lift
• Breast Reduction
• Captique
• Chin and Cheek Reshaping
• Collagen
• Ear Correction
• Eyelid Surgery
• Face Lift
• Forehead Lift
• Fraxel
• Juvéderm™
• Labial Reduction*
• Lap-Band®*
• Lip Augmentation
• Liposuction
• Male Breast Reduction
• Microdermabrasion
• Neck Lift
• Nose Reshaping
• Podiatry*
• Post Gastric By-Pass
• Restylane
• Thermage
• Thigh Lift
• Tummy Tuck
• Vaginal Rejuvenation*

The U.S. Food and Drug Administration (FDA) has granted market approval for Captique Injectable gel -- a new dermal filler product based on Genzyme's non-animal stabilized hyaluronic acid (HA) technology.

The way your skin looks is directly related to the way your skin is supported. As we age, the natural support layers in the skin break down resulting in the formation of wrinkles.

Captique, a clear gel containing a purified form of hyaluronic (h¬Øi ‘?a-l¬Øu -ron’ik) acid, adds volume lost during the aging process by temporarily smoothing out facial lines and wrinkles.

Captique is injected just under the skin’s surface in order to temporarily correct wrinkles.

Captique is the newest hyaluronic acid entry into the U.S. dermal filler marketplace. It is indicated for the correction of moderate to severe facial wrinkles and is manufactured by Genzyme. Inamed is Genzyme's exclusive U.S. marketing and distribution partner for Captique.